Letter: Food and Drug Administration Clearance of Transcranial Magnetic Stimulation for Adolescent Depression in the Absence of Data Supporting Efficacy
Restricted accessLetterFirst published online August, 2025
Letter: Food and Drug Administration Clearance of Transcranial Magnetic Stimulation for Adolescent Depression in the Absence of Data Supporting Efficacy
AboyM, CrespoC, SternA. Beyond the 510(k): The regulation of novel moderate-risk medical devices, intellectual property considerations, and innovation incentives in the FDA’s De Novo pathway. NPJ Digit Med, 2024; 7(1):29; doi: 10.1038/s41746-024-01021-y
2.
BridgeJA, BirmaherB, IyengarS, et al.Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry, 2009; 166(1):42–49; doi: 10.1176/appi.ajp.2008.08020247
3.
Center for Devices and Radiological Health. (2024a) NeuroStar 510(k) PMN K231926 summary. Silver Spring, MD: U.S. Food and Drug Administration.
CroarkinPE, ElmaadawiAZ, AaronsonST, et al.Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: A double-blind, randomized, sham-controlled trial. Neuropsychopharmacology, 2021; 46(2):462–469; doi: 10.1038/s41386-020-00829-y
7.
DwyerJB, StringarisA, BrentDA, et al.Annual research review: Defining and treating pediatric treatment‐resistant depression. J Child Psychol Psychiatry, 2020; 61(3):312–332; doi: 10.1111/jcpp.13202
8.
MossmanSA, MillsJA, WalkupJT, et al.The impact of failed antidepressant trials on outcomes in children and adolescents with anxiety and depression: A systematic review and meta-analysis. J Child Adolesc Psychopharmacol, 2021; 31(4):259–267; doi: 10.1089/cap.2020.0195
9.
NasirM, LiF, CourleyS, et al.Meta-analysis: Pediatric placebo response in depression trials does not replicate in anxiety and obsessive-compulsive disorder trials. J Child Adolesc Psychopharmacol, 2021; 31(10):670–684; doi: 10.1089/cap.2021.0030
10.
Neuronetics. (2024). NeuroStar TMS Therapy for Depression—Healthcare Provider Information | NeuroStar. NeuroStar. Available from: https://neurostar.com/hcp/
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
